Medication-assisted therapies - Tackling the opioid-overdose epidemic

New England Journal of Medicine

Volumn 370, Issue 22, 2014, Pages 2063-2066

  Volkow, Nora D ^a   Frieden, Thomas R ^d   Hyde, Pamela S ^b   Cha, Stephen S ^c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

^c CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; DEPADE; METHADONE; NALTREXONE; UNCLASSIFIED DRUG;

CAUSE OF DEATH; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG INTOXICATION; DRUG MONITORING; DRUG SAFETY; DRUG UTILIZATION; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; OPIATE ADDICTION; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

ANALGESICS, OPIOID; DRUG AND NARCOTIC CONTROL; DRUG OVERDOSE; EPIDEMICS; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; INSURANCE COVERAGE; MEDICAID; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; UNITED STATES;

EID: 84901785133     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1402780     Document Type: Article

References (5)

1. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657-9.
2. Addressing prescription drug abuse in the United States: current activities and future opportunities. Atlanta: Centers for Disease Control and Prevention, 2013 (http://www.cdc.gov/homeandrecreationalsafety/overdose/hhs-rx- abuse.html).
3. Schwartz RP, Gryczynski J, O'Grady KE, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am J Public Health 2013;103:917-22.
4. Knudsen HK, Abraham AJ, Roman PM. Adoption and implementation of medications in addiction treatment programs. J Addict Med 2011;5:21-7.
5. Clark RE, Baxter JD. Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good? JAMA Intern Med 2013;173:1571-2.